VentriPoint Diagnostics Ltd.

OTCPK:VPTD.F Stock Report

Market Cap: US$25.9m

VentriPoint Diagnostics Management

Management criteria checks 2/4

VentriPoint Diagnostics' CEO is Hugh MacNaught, appointed in Feb 2024, has a tenure of less than a year. directly owns 0.025% of the company’s shares, worth $6.59K. The average tenure of the management team and the board of directors is 1.9 years and 4.3 years respectively.

Key information

Hugh MacNaught

Chief executive officer

CA$37.6k

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.03%
Management average tenure1.9yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

CEO

Hugh MacNaught

less than a year

Tenure

CA$37,633

Compensation

Mr. Hugh MacNaught served as an Independent Director at VentriPoint Diagnostics Ltd since September 2020 and serves as its Interim CEO, President & Director since February 2024. He served as an Executive V...

Leadership Team

NamePositionTenureCompensationOwnership
George Adams
Executive Chairman & Corporate Secretary13.5yrsCA$346.83k0.60%
CA$ 155.1k
Hugh MacNaught
Interim CEOless than a yearCA$37.63k0.025%
CA$ 6.6k
Jimmy Jeon
Chief Financial Officerless than a yearno datano data
Hirotaka Katagiri
CTO & Business Development Division Director3.3yrsno datano data
Jim Graba
Application Specialist & Chief Trainer5.9yrsno datano data

1.9yrs

Average Tenure

Experienced Management: VPTD.F's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
George Adams
Executive Chairman & Corporate Secretary13.5yrsCA$346.83k0.60%
CA$ 155.1k
Hugh MacNaught
Interim CEO3.6yrsCA$37.63k0.025%
CA$ 6.6k
Robert Hodgkinson
Independent Director4.3yrsCA$18.14k1.46%
CA$ 378.8k
Samuel Schwartz
Chair of Business Advisory Committee6.1yrsno datano data
Scott D. Solomon
Member of Scientific Advisory Board12.1yrsno datano data
Randy AuCoin
Independent Director2.3yrsCA$99.20kno data
David Sahn
Member of Scientific Advisory Boardno datano datano data
Mark Lewin
Member of Scientific Advisory Boardno datano datano data
Michael Gatzoulis
Member of Scientific Advisory Boardno datano datano data
Richard Krasuski
Member of Scientific Advisory Board12.9yrsno datano data
Fiona Fitzgerald
Independent Director2.5yrsCA$113.18kno data
Gregory Skinner
Member of Board of Clinical Advisors2.2yrsno datano data

4.3yrs

Average Tenure

Experienced Board: VPTD.F's board of directors are considered experienced (4.3 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.